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There has been extensive research on post-viral fatigue, and the present mini-review and 
commentary provides an overview of the effects associated with different infecting agents. Fatigue 
is not only a subjective state, rather it has an impact on our ability to carry out everyday functions, 
and its effect can be demonstrated using performance tasks. It is not surprising, therefore, that 
persistent effects of COVID-19 are observed, and the key features of Long Covid are reviewed 
here, Suggestions for further research which will provide a better understanding of Long Covid and 
provide a basis for prevention and management are also discussed. 
 
 




1.1 Post-viral Fatigue 
 
The present mini-review and commentary article 
aims to provide a concise summary of post-viral 
fatigue that can be understood by all readers. It 
has two main objectives. The first is to 
demonstrate that post-viral fatigue is frequent 
and common, and can be observed following 
infection with many different viruses. Generally, 












of the illness, and may in part reflect the recovery 
observed in any severe illness. The second aim 
is to describe the persistent effects seen after 
COVID-19 infection, and the condition now 
referred to as Long Covid. Following this, the 
questions that need to be addressed by future 
research are outlined. 
 
This article has the following structure. First, 
post-viral effects of common upper respiratory 
tract infections (the common cold and influenza) 
are described. Following this, infections that lead 
to more persistent fatigue (e.g. Infectious 
mononucleosis) are discussed. This is followed 
by an account of the chronic fatigue following 
infection with herpes viruses and enteroviruses. 
Possible mechanisms underlying post-viral 
fatigue are then discussed. This is followed by a 
description of the chronic symptoms reported by 
some individuals following COVID-19 illnesses 
and now referred to as Long Covid. Long Covid 
is a new condition, and the research questions 
that need to be addressed are presented here. 
 
1.2 After-effects of the Common Cold 
 
There has been extensive research on the 
effects of both experimentally-induced colds [1-6] 
and naturally-occurring colds [7-10] on 
performance. After-effects of experimentally-
induced rhinovirus infections were examined in 
one study [11]. These results showed that the 
slower reaction times observed when the person 
was symptomatic were still present after the 
symptoms had gone. After-effects of naturally-
occurring colds were observed in another study, 
but the tasks that were impaired differed from 
those that were sensitive during the symptomatic 
phase [12]. These results showed that the slower 
reaction times observed when the person was 
symptomatic were still present after the 
symptoms had gone. This could reflect the 
immunological changes that still occur after the 
symptoms have gone. Another possibility is that 
the volunteers had learnt the task when 
symptomatic, and this poor learning continued at 
the next test session when they were well. A 
study of the effects of naturally-occurring                   
colds [13] supported the poor learning 
explanation. 
 
1.3 After-effects of Influenza 
 
Post-viral fatigue following influenza can last for 
weeks rather than days. An early report [14] 
described anecdotal reports of accidents before 
and after influenza. Later research [15] 
suggested that the evidence for influenza 
encephalopathy (drowsiness, confusion and 
epileptiform events) is well established. Post-
influenza effects may occur, and these can 
influence the judgements of highly skilled staff as 
illustrated by the following case: 
 
“The individual concerned was responsible for 
calibration of a spectrophotometer before 
commencing a day’s work ------ He had 
previously been off work for two days with 
influenza and returned alleging health ----- During 
the first part of the morning, he made eleven 
attempts to correctly prepare the instrument. On 
six occasions he stated his opinion that all the 
preparative procedures had been completed and 
that the instrument was ready for use. Each time, 
however, elementary faults were observed. 
Despite the incorrectness of the last calibration, 
the individual commenced work, compiling 
results which were finally discarded by himself 
three weeks later.” 
 
Other research has examined the effects of post-
viral fatigue following influenza on the 
performance of a battery of cognitive tasks [16]. 
The results showed impairments in reaction time, 
increased distraction, and poorer episodic and 
semantic memory.  
 
1.4 Tularemia (Rabbit Fever) 
 
One of the earliest studies of experimentally-
induced infection [17, 18] induced a febrile 
disease characterised by headache, nausea, 
myalgia and depression. The results showed that 
those who became ill had an average drop in 
performance of over 25%, and after recovery, 
they were still 15% below the healthy control 
group. 
 
1.5 Infectious Mononucleosis (IM) 
 
While IM is usually a self-limiting disease, it is 
now recognised that in a minority of previously 
normal patients, symptoms and signs may 
persist for months or years after the initial 
diagnosis [19-25]. Research [26] has shown that 
the post-viral effects of IM include impairments of 
episodic and working memory which are similar 
to effects observed in chronic fatigue syndrome 
[27, 28]. Indeed, Epstein Barr viruses have been 
implicated as the possible causal mechanism of 
chronic fatigue syndrome [29]. 
 
1.6 Others Viruses that Lead to Post-Viral 
Fatigue 
 
A recent review [30] has examined chronic viral 











1.6.1 Human Herpesviruses 
 
There are nine human herpesviruses and 
members of the Herpesviridae family, Beta-
herpesvirinae subfamily, and Roseolovirus genus 
are the most widely studied pathogens in chronic 
fatigue syndrome. Rasa et al. [30] reviewed 
twenty-nine studies investigating associations 
between human herpesvirus 6 and/or 7 and 
chronic fatigue syndrome. Eleven of these 
studies revealed a correlation between these 
viruses and chronic fatigue syndrome. Some of 
this research should be treated with caution due 
to small sample sizes. There is also the 
possibility that these infections can contribute to 
a sub-group of patients rather than the whole 
sample. The viruses could also trigger other 
responses, such as autoimmune, metabolic and 
psychological disturbances, which could be 




There are more than 70 different enteroviruses 
that can infect humans. The role of enteroviruses 
in chronic fatigue syndrome has been suspected 
for over three decades, but the data from the 
literature have been controversial. Rasa et al. 
[30] reviewed sixteen studies investigating 
enteroviruses in chronic fatigue syndrome. 
Eleven of these studies showed an association 
between enteroviruses and chronic fatigue 
syndrome. 
 
1.6.3 Human parvovirus 
 
B19V is an immunomodulating single-strand 
DNA virus belonging to the Parvoviridae family 
(Parvoviridnae subfamily, Erythrovirus genus). 
Studies of this virus and chronic fatigue 




XMRV belongs to the Retroviridae family 
(Orthoretrovirinae subfamily, Gammaretrovirus 
genus). Despite early suggestions that this was 
present in those with chronic fatigue syndrome, 
later research in many countries failed to 
replicate these findings. Other retroviruses 
(HTLV-I and II, HIV-1/2 and spuma viruses) have 
also been studied. However, a retroviral 
aetiology in chronic fatigue syndrome has not 
been supported. 
 
1.6.5 Ross river virus 
 
Another virus that causes post-viral fatigue is a 
single-stranded positive-sense RNA virus – Ross 
River virus (RRV). Early research [31] showed 
that post-viral fatigue was present up to thirty 
months after the initial infection with RRV. Such 
disorders were correlated with elevated levels of 
pro-inflammatory cytokines [32] which may 
influence the CNS. 
 
1.7 Mechanisms Linking Viral Infections 
to Chronic Fatigue 
 
One commonality between viruses linked to 
chronic fatigue syndrome is that they establish 
persistent infections. In order to do this, the 
viruses must evade immune cells and alter 
immune cell function [see 30 for a review]. 
Persistent infection is related to 
immunosuppression and activated immune 
complexes, which may result in chronic 
inflammation. This may lead to alterations in the 
regulation of cytokine production. An increase of 
inflammatory mediators might explain the 
symptoms of chronic fatigue syndrome. Viral 
infection may also influence cellular immunity, 
which then leads to viral re-activation. 
 
Chronic fatigue has also been considered to be a 
mitochondrial disease [33]. Many of the viruses 
mentioned above can modify host mitochondria 
in a variety of ways which can provide plausible 
explanations for their involvement in chronic 
fatigue syndrome. The viruses implicated in 
chronic fatigue syndrome influence mitochondrial 
metabolism and bioenergetics in a variety of 
ways. The end points of this are enhanced viral 
replication and defence against anti-viral 
mechanisms. 
 
Viruses contribute to autoimmune diseases in a 
variety of ways and autoimmune signature in 
chronic fatigue syndrome has become a topic of 
recent interest [34]. At least in a subset of 
patients, elements of autoimmunity and 
mitochondrial dysfunction observed in chronic 
fatigue may have a viral pathogenesis. It may be 
that an underlying immune dysfunction acts as a 
predisposing factor to either an exceptionally 
strong acute infection, an inability to clear the 
virus or both. Lack of analysis of molecular 
mechanisms linking viral pathogens to chronic 
fatigue syndrome has restricted our 
understanding of the condition. 
 
2. LONG COVID 
 
Most people infected with SARS-2-CoV-2 either 
remain asymptomatic or recover quickly. 











symptoms [35-37], and this has been referred to 
as Long Covid [38]. As the emergence of Long 
Covid is very recent, it is not too surprising that 
we know relatively little about it. Factors which 
predispose people to Long Covid are poorly 
understood, and the incidence of it is unknown. 
Little is known about the pathogenesis or 
duration of Long Covid. There is a lack of 
awareness of the syndrome, no known 
treatment, but a realisation that it may become a 
significant world health issue. 
 
2.1 Symptoms Reported by Those with 
Long Covid 
 
The symptoms reported by those with Long 
Covid are many and varied. Table 1 shows 
examples of the symptoms. 
 
The above symptoms vary between individuals 
and may also show changes from day to day                         
in a given individual. Long Covid shows a                       
strong resemblance to chronic fatigue                      
syndrome, and patients have had their symptoms 
ascribed to mental health problems. Research on 
Long Covid started with anecdotal reports and 
more detailed case histories [39]. This was 
followed by retrospective studies from a number 
of countries. These examined the percentage of 
patients with Long Covid lasting thirty days or 
more. All studies reported that over fifty per cent 
of their samples reported fatigue, and                                 
this was true from thirty to seventy-five days after 
the onset of the symptoms. One prospective 
study [40] found that in a cohort of Long Covid 
patients studied four months after onset, 
impairment was observed in one or more                            
organ systems. However, these result contrast 
with those from Wuhan, China, where                             
eighty-six per cent of patients were 
asymptomatic three or four weeks after 
discharge from the hospital. 
 
2.2 Future Research on Long Covid 
 
Many of the questions that need to be addressed 
about Long Covid are those which researchers 
have covered in past research on post-viral and 
chronic fatigue syndrome. These issues are 
summarised in Table 2.  
 
Table 1. Symptoms of Long Covid 
 
Severe Fatigue 





Vertigo or tinnitus 
Palpitations 
Anosmia or ageusia 
Cognitive problems – “brain fog” 
Peripheral neuropathy 
Skin rash 
Anxiety and depression 
 
Table 2. Long Covid: Future research issues 
 
1. A case definition is needed. 
2. Is Long Covid a single syndrome or are there a number of distinct syndromes? 
3. Are there distinct groups of symptoms? e.g. respiratory v systemic symptoms 
4. Is the length of symptoms the best method of classifying sub-groups? 
5. What physiological systems are affected in Long Covid (cardiovascular; pulmonary; CNS; 
renal function; muscles)? 
6. What percentage of infected people develop Long Covid (what is the incidence of Long 
Covid)? 
7. What are the risk factors for developing Long Covid? 
8. What mechanisms underlie the persistence of Long Covid? (genetics; viral persistence; 
immunological changes; inflammation; biochemistry and haematology)? 
9. What are the best methods of preventing and managing Long Covid? 
10. There is a need to raise awareness of Long Covid and to engage all stakeholders in the 













Post-viral fatigue has been recognised                               
and studied for a long time. The present                            
article summarises previous research                          
on post-viral fatigue. Upper respiratory tract 
infections often lead to short-lived fatigue, and 
this demonstrates the importance of considering 
time periods when the person no longer                               
has the acute symptoms. More severe infections 
can lead to long-lasting fatigue, and there is good 
evidence that human herpesviruses and 
enteroviruses can lead to chronic fatigue 
syndrome. It is not surprising, therefore, that a 
severe disease such as COVID-19 can                            
lead to persistent syndromes. Long Covid                          
has recently been recognised, and the features 
of the condition are described here. At the 
moment, we are at the stage of having identified 
the condition. Further urgent research is now 
required to get a better understanding of 
underlying risk factors and mechanisms, and to 


















1. Smith AP. Twenty-five years of research 
on the behavioural malaise associated with 





2. Smith AP, Tyrrell DAJ, Coyle K, Willman 
JS. Selective effects of minor illnesses on 
human performance.  Brit J Psychol. 
1987;78:183-188.   
DOI:10.1111/j.2044-8295.1987.tb02238.x 
3. Smith AP, Tyrrell DAJ, Al-Nakib W, Coyle 
KB, Donovan CB, Higgins PG, Willman JS. 
Effects of experimentally-induced virus 
infections and illnesses on psychomotor 
performance. Neuropsychobiology. 1987; 
18:144-148.  
DOI: 10.1159/000118408 
4. Smith AP, Tyrrell DAJ, Al-Nakib W, Coyle 
KB, Donovan CB, Higgins PG, Willman JS. 
The effects of experimentally-induced 
respiratory virus infections on 
performance. Psychol Med. 1988;18:65-
71.
DOI: 10.1017/s0033291700001896 
5. Smith AP, Tyrrell DAJ, Barrow GI, Coyle 
KB, Higgins PG, Trickett S, Willman JS. 
The effects of experimentally induced 
colds on aspects of memory.  Percept Mot 
Skills. 1990;71:1207-1215.  
DOI: 10.2466/pms.1990.71.3f.1207 
6. Smith AP, Tyrrell DAJ, Barrow GI, Higgins 
PG, Willman JS, Bull S, Coyle KB, Trickett 
S. Mood and experimentally-induced 
respiratory virus infections and illnesses. 
Psychol Health. 1992;6:205-212.  
DOI: 10.1080/08870449208403184  
7. Smith A, Thomas M, Kent J, Nicholson K. 
Effects of the common cold on mood and 
performance. Psychoneuroendocrinology. 
1998;23:733-739.  
8. Smith A, Rich N, Sturgess W, Brice C, 
Collison C, Bailey J, Wilson S, Nutt D.  
Effects of the common cold on subjective 
alertness, simple and choice reaction time 
and eye movements.  Journal of 
Psychophysiology. 1999;13:145-151 
9. Smith AP, Thomas M, Whitney H. Effects 
of upper respiratory tract illnesses on 
mood and performance over the working 
day. Ergonomics. 2000;43:752-763. 
10. Smith AP. Effects of the common cold on 
mood, psychomotor performance, the 
encoding of new information, speed of 
working memory and semantic processing. 




11. Smith AP, Tyrrell DAJ, Al-Nakib W, Barrow 
GI, Higgins PG, Leekam S, Trickett S, 
Effects and after-effects of the common 
cold and influenza on human performance.  
Neuropsychobiology. 1989;21:90-93.  
DOI: 10.1159/000118558 
12. Hall SR, Smith AP. An investigation of the 
effects and after-effects of naturally-
occurring upper respiratory tract illnesses 
on mood and performance.  Physiology 











13. Smith AP, Thomas M, Whitney, H. After-
effects of the common cold on mood and 
performance. Ergonomics. 2000;43:1342-
1349. 
14. Tye J. The invisible factor: An inquiry into 
the relationship between influenza and 
accidents. London: British Safety Council; 
1960. 
15. Grant J. Post-influenzal judgement 
deflection among scientific personnel. 
Asian Journal of Medicine. 1972;8:535-
539. 
16. Smith AP. Chronic fatigue syndrome and 
performance. In: Handbook of Human 
Performance, Health and Performance. 
(eds) A. P. Smith & D.M. Jones. London: 
Academic Press. 1992;2:261-278. 
17. Alluisi EA, Thurmond JB, Coates GD. 
Behavioral effects of infectious disease: 
respiratory Pasteurella tularensis in man. 
Perceptual and Motor Skills. 1971;32:647-
688. 
18. Alluisi EA, Beisel WR, Bartelloni PJ, 
Coates GD. Behavioral effects of 
tularensis and sandfly fever in man. 
Journal of Infectious Diseases. 
1971;128:710-717. 
19. Henle W, Henle G, Lennete ET. The 
Epstein Barr virus. Scientific American. 
1979; 241: 49-59. 
20. Isaacs R. Chronic infectious 
mononucleosis. Blood. 1948;3:858-861. 
21. Masuci MG, Szigeti R, Ernberg I,                               
et al. Cellular immune defects to Epstein 
Barr virus determined antigens in young 
males. Cancer Research. 1981;1:4284-
4291. 
22. Tobi M, Moag A, Ravid Z, et al.                       
Prolonged atypical illness associated with 
serological evidence of persistent                   
Epstein Barr virus infection. Lancet. 
1982;I:61-64. 
23. Hamblin TJ, Hussain J, Akbar AN,                     
et al. Immunological reason for chronic ill-
health after infectious mononucleosis. 
British Medical Journal. 1983;287:                    
85-88.  
24. Dubois RE, Seeley JK, Bous I, et al. 
Chronic mononucleosis syndrome. South 
Medical Journal. 1984;77:1376-1382. 
25. Jones JF, Ray G, Minnich LL, et al. 
Evidence for Active Epstein-Barr Virus 
Infection in Patients with Persistent, 
Unexplained Illnesses: Elevated Anti-Early 
Antigen Antibodies. Ann Intern Med. 
1985;102:1-7. 
26. Hall SR, Smith AP. Behavioural effects of 
infectious mononucleosis. 
Neuropsychobiology. 1996;33:202-209. 
27. Smith AP, Behan PO, Bell W, Millar K, 
Bakheit M.  Behavioural problems 
associated with the chronic fatigue 
syndrome. British Journal of Psychology. 
1993;84:411-423. 
28. Thomas MA, Smith AP. An investigation 
into the cognitive deficits associated with 
chronic fatigue syndrome. The Open 
Neurology Journal. 2009;3:13-23.  
DOI: 10.2174/1874205X009030010013  
29. Holmes GP, Kaplan JE, Stewart JA, et al. 
A cluster of patients with chronic 
mononucleosis-like syndrome. Is Epstein-
Barr virus the cause? JAMA. 1987;257: 
2297-2302 
30. Rasa S, Nora-Krukle Z, Henning N. et al. 
Chronic viral infections in myalgic 
encephalomyelitis/chronic fatigue 
syndrome (ME/CFS). Journal of 
Translational Medicine. 2018;16:268. 
Available: https://doi.org/10.1186/s12967-
018-1644-y 
31. Selden SM, Cameron AS. Changing 
epidemiology of Ross River virus disease 
in South Australia. Med J Aust. 2016; 
165:313–7. 
32. Vollmer-Conna U, Fazou C, et al. 
Production of pro-inflammatory cytokines 
correlates with the symptoms of acute 
sickness behaviour in humans. Psychol 
Med. 2004;34:1289–97. 
33. Filler K, Lyon D, Bennett J, et al.  
Association of mitochondrial dysfunction 
and fatigue: A review of the literature. BBA 
Clin. 2014;1:12–23. 
34. Blomberg J, Gottfries CG, Elfaitouri A, et 
al. Infection elicited autoimmunity and 
myalgic encephalomyelitis/chronic fatigue 
syndrome: An explanatory model. Front 
Immunol. 2018;9:229. 
35. Carfi A, Bernabel, R, Landi F. Persistent 
symptoms in patients after acute COVID-
19. JAMA. 2020;603.  
DOI:10.1001/jama.2020.12603 
36. NHS. After-care needs of inpatients 
recovering from COVID-19; 2020.  
Available:https://www.pcrs-uk,org/pcrs-
uk.org/files/nhs-aftercarecovid.pdf 
37. Public Health England. COVID-19: long-














38. The Royal Society.  Long Covid: what is it, 




39. NIHR. Living with Covid19; 2020.  
Available:https://evidence.nihr.ac.uk/theme
dreview/living-with-covid19/ 
40. Dennis, A. et al. Mulit-organ impairment in 




© 2021 Smith; This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, 






The peer review history for this paper can be accessed here: 
http://www.sdiarticle4.com/review-history/63884 
